Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSAMG 18 is an inhibitor of inositol-requiring enzyme 1α (IRE1α; IC50 = 0.013 µM).1 It is selective for IRE1α over JNK3 (IC50 = 2.5 µM) and a panel of 100 kinases at 1 µM. AMG 18 inhibits the splicing of X-box binding protein 1 (XBP1) induced by thapsigargin (Item No. 10522) in a reporter assay using HT-1080 cells. It sensitizes 9591PPT and 53631PPT mouse pancreatic ductal adenocarcinoma (PDAC) cells to radiation when used at concentrations of 2.5 or 5 µM.2 AMG 18 (10 µM) reverses increases in fibronectin levels in primary human small airway epithelial cells infected with respiratory syncytial virus (RSV).3 In vivo, AMG 18 (50 mg/kg) decreases blood glucose levels, liver triglyceride and cholesterol levels, and plasma alanine transaminase (ALT) and aspartate aminotransferase (AST) levels in a mouse model of non-alcoholic steatohepatitis (NASH) induced by a methionine- and choline-deficient (MCD) diet.4
WARNING This product is not for human or veterinary use.
1. Unfolded protein response in cancer: IRE1α inhibition by selective kinase ligands does not impair tumor cell viability. ACS Med. Chem. Lett. 6(1), 68-72 (2014).
2. Identification of the unfolded protein response pathway as target for radiosensitization in pancreatic cancer. Radiother. Oncol. 191:110059, (2024).
3. The IRE1α-
4. KIRA8 attenuates non-